Healthcare entity
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ADMA Biologics, Inc., the most common co-covered peer. The tracked stories average 4 original sources each. Omnipod 5 appears in 1 tracked Healthcare story from July 12, 2026.
Last mentioned: Jul 12, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention ADMA Biologics, Inc., the most common co-covered peer. The tracked stories average 4 original sources each. Omnipod 5 appears in 1 tracked Healthcare story from July 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Omnipod 5. Shared-story counts are live from our verified record — not editorial picks.
Medical device makers Insulet and Embecta face class actions alleging hidden defects and demand weaknesses for insulin delivery products, causing steep investor losses.
Omnipod 5 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
